Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinoma

BACKGROUND: The challenging diagnosis and poor prognosis of cholangiocarcinoma require the determination of biomarkers. Autoantibodies could be used in the clinic as diagnostic markers for the early detection of tumours. By proteomic approaches, several autoantibodies were proposed as potential mark...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustafa, Mohammad Zahid, Nguyen, Viet Hung, Le Naour, François, De Martin, Eleonora, Beleoken, Elvire, Guettier, Catherine, Johanet, Catherine, Samuel, Didier, Duclos-Vallee, Jean-Charles, Ballot, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715332/
https://www.ncbi.nlm.nih.gov/pubmed/26774260
http://dx.doi.org/10.1186/s12967-015-0751-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715332/
https://www.ncbi.nlm.nih.gov/pubmed/26774260
http://dx.doi.org/10.1186/s12967-015-0751-2

Ejemplares similares